WO2005021724A3 - Gp115: methodes et compositions permettant de traiter le cancer - Google Patents
Gp115: methodes et compositions permettant de traiter le cancer Download PDFInfo
- Publication number
- WO2005021724A3 WO2005021724A3 PCT/US2004/027968 US2004027968W WO2005021724A3 WO 2005021724 A3 WO2005021724 A3 WO 2005021724A3 US 2004027968 W US2004027968 W US 2004027968W WO 2005021724 A3 WO2005021724 A3 WO 2005021724A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treating cancer
- compositions
- methods
- gene
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/82—Translation products from oncogenes
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Biophysics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention concerne l'utilisation de molécules concernant le gène GP115 (C17orf26) pour traiter le cancer et d'autres états hyperprolifératifs. L'invention concerne également des mammifères non humains hébergeant une modification génétique concernant le gène GP115 et leur utilisation comme modèles expérimentaux du cancer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49839303P | 2003-08-27 | 2003-08-27 | |
US60/498,393 | 2003-08-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005021724A2 WO2005021724A2 (fr) | 2005-03-10 |
WO2005021724A3 true WO2005021724A3 (fr) | 2005-05-12 |
Family
ID=34272666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/027968 WO2005021724A2 (fr) | 2003-08-27 | 2004-08-27 | Gp115: methodes et compositions permettant de traiter le cancer |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005021724A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112394168B (zh) * | 2019-08-15 | 2023-02-14 | 中山大学附属第六医院 | IgA2检测试剂在制备KRAS突变型结直肠癌诊断剂方面的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012662A2 (fr) * | 1999-08-17 | 2001-02-22 | Incyte Genomics, Inc. | Proteines associees a la membrane |
WO2003039443A2 (fr) * | 2001-11-05 | 2003-05-15 | Deutsches Krebsforschungszentrum | Nouveaux marqueurs genetiques pour leucemies |
-
2004
- 2004-08-27 WO PCT/US2004/027968 patent/WO2005021724A2/fr active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001012662A2 (fr) * | 1999-08-17 | 2001-02-22 | Incyte Genomics, Inc. | Proteines associees a la membrane |
WO2003039443A2 (fr) * | 2001-11-05 | 2003-05-15 | Deutsches Krebsforschungszentrum | Nouveaux marqueurs genetiques pour leucemies |
Non-Patent Citations (4)
Title |
---|
BAGHERI-FAM STEFAN ET AL: "Comparative genomics of the SOX9 region in human and Fugu rubripes: Conservation of short regulatory sequence elements within large intergenic regions", GENOMICS, vol. 78, no. 1-2, November 2001 (2001-11-01), pages 73 - 82, XP002312982, ISSN: 0888-7543 * |
FRASER A G ET AL: "Functional genomic analysis of C. Elegans chromosome I by systematic RNA interference", NATURE, MACMILLAN JOURNALS LTD. LONDON, GB, vol. 408, 16 November 2000 (2000-11-16), pages 325 - 330, XP002953443, ISSN: 0028-0836 * |
MCMANUS M T ET AL: "Gene silencing in mammals by small interfering RNAs", NATURE REVIEWS GENETICS, MACMILLAN MAGAZINES, GB, vol. 3, October 2002 (2002-10-01), pages 737 - 747, XP002973403 * |
WALHOUT ALBERTHA J M ET AL: "Integrating interactome, phenome, and transcriptome mapping data for the C. elegans germline.", CURRENT BIOLOGY : CB. 19 NOV 2002, vol. 12, no. 22, 19 November 2002 (2002-11-19), pages 1952 - 1958, XP002312983, ISSN: 0960-9822 * |
Also Published As
Publication number | Publication date |
---|---|
WO2005021724A2 (fr) | 2005-03-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006073839A3 (fr) | Proteases antifongiques acides | |
WO2004013280A3 (fr) | Silençage genique a mediation par arnsi specifique des alleles | |
WO2003102214A3 (fr) | Procede d'interference efficace par arn dans des cellules de mammifere | |
WO2007031877A3 (fr) | Modulation de proprietes immunostimulantes de petits arn interferents (petits arni) par modification de nucleotides | |
AU2003202585A1 (en) | Disubstituted thiazolyl carboxanilides and their use as microbicides | |
AU2003297474A1 (en) | Methods of inhibiting gene expression by rna interference | |
WO2004013310A3 (fr) | Methodes de diminution d'expression de gene cible in vivo par introduction d'arn interferant | |
WO2005059097A3 (fr) | Procedes de production a fidelite elevee de longues molecules d'acide nucleique | |
AU2003258452A1 (en) | Rna interference based methods and compositions for inhibiting hbv gene expression | |
AU2003243541A1 (en) | Methods and compositions relating to labeled rna molecules that reduce gene expression | |
AU2003213054A1 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF POLYCOMB GROUP PROTEIN EZH2 GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) | |
WO2004063185A8 (fr) | Thiophene carboxamides utilises en tant qu'inhibiteurs de l'enzyme ikk-2 | |
WO2005001039A3 (fr) | Production de petits arn interferents (arnsi) regulee par les ribozymes et procedes d'utilisation de ceux-ci | |
WO2006066153A8 (fr) | Chromoproteine d'actinomadura, apoproteine et groupe de genes | |
AU2003233717A1 (en) | Methods and compositions for treating neoplasia relating to hnrnp a1 and a2 nucleic acid molecules | |
WO2002059322A3 (fr) | Compositions et methodes liees a la famille de genes biosynthetiques de la daptomycine | |
WO2003014297A3 (fr) | Compositions et procedes relatifs a la famille multigenique biosynthetique de la daptomycine | |
WO2005014607A3 (fr) | Modulation antisens de l'expression de la stearoyl-coa desaturase | |
WO2005021724A3 (fr) | Gp115: methodes et compositions permettant de traiter le cancer | |
AU2003238899A1 (en) | Method of controling acetylation of metabolic enzymes | |
WO2005001031A3 (fr) | Modulation de la voie d'interference arn | |
WO2006053125A3 (fr) | Gp201: procedes et compositions de traitement du cancer | |
WO2004072023A3 (fr) | Oxathiine-carboxamides | |
WO2005042480A3 (fr) | Pyrazolylcarboxanilides n-substitues | |
WO2005012275A3 (fr) | Composes benzo[1,2,5]thiadiazole |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase |